Amiselimod, a novel sphingosine 1-phosphate receptor-1 modulator, has potent therapeutic efficacy for autoimmune diseases, with low bradycardia risk.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Works matching IS 00071188 AND DT 2017 AND VI 174 AND IP 1
Results: 10
1
2
Issue Information.
- Published in:
- British Journal of Pharmacology, 2017, v. 174, n. 1, p. 1, doi. 10.1111/bph.13584
- Publication type:
- Article
3
Histamine H<sub>4</sub> receptor agonist-induced relief from painful peripheral neuropathy is mediated by inhibition of spinal neuroinflammation and oxidative stress.
- Published in:
- 2017
- By:
- Publication type:
- journal article
4
The protective effect of the natural compound hesperetin against fulminant hepatitis in vivo and in vitro.
- Published in:
- 2017
- By:
- Publication type:
- journal article
5
The peptide Phα1β, from spider venom, acts as a TRPA1 channel antagonist with antinociceptive effects in mice.
- Published in:
- 2017
- By:
- Publication type:
- journal article
6
The SPARC protein: an overview of its role in lung cancer and pulmonary fibrosis and its potential role in chronic airways disease.
- Published in:
- 2017
- By:
- Publication type:
- journal article
7
Physiologically relevant binding affinity quantification of monoclonal antibody PF-00547659 to mucosal addressin cell adhesion molecule for in vitro in vivo correlation.
- Published in:
- 2017
- By:
- Publication type:
- journal article
8
Celastrol prevents cadmium-induced neuronal cell death by blocking reactive oxygen species-mediated mammalian target of rapamycin pathway.
- Published in:
- 2017
- By:
- Publication type:
- journal article
9
The suppression of bromodomain and extra-terminal domain inhibits vascular inflammation by blocking NF-κB and MAPK activation.
- Published in:
- 2017
- By:
- Publication type:
- journal article
10
Erratum.
- Published in:
- 2017
- Publication type:
- journal article